Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2022 Feb 11;2(1):e101.
doi: 10.1002/ski2.101. eCollection 2022 Mar.

A case of anti-laminin gamma-1 (p200) pemphigoid with bullous lesions on the lips, hands and feet showing antibodies to desmoglein 1

Affiliations
Case Reports

A case of anti-laminin gamma-1 (p200) pemphigoid with bullous lesions on the lips, hands and feet showing antibodies to desmoglein 1

F Kaneko et al. Skin Health Dis. .

Abstract

An 87-years-old-man presented with bullous and erosive lesions exclusively on the lips, hands and feet. Histopathological and direct immunofluorescence studies suggested the diagnosis of bullous pemphigoid, but the serum anti-BP180 antibodies were negative. Strangely, anti-desmoglein 1 antibodies were positive, although no pemphigus-like features were found. Indirect immunofluorescence showed IgG reactivity with dermal side of 1 M NaCl-split skin. Immunoblotting showed positive reactivity with the 200 kDa laminin gamma-1 but not with type VII collagen. After the administration of prednisolone 20 mg/day, bullous lesions cleared within 2 weeks.

PubMed Disclaimer

Conflict of interest statement

None to declare.

Figures

FIGURE 1
FIGURE 1
Clinical features (a) on the lips, (b) on the dorsal hands, and (c) soles
FIGURE 2
FIGURE 2
The results of (a) histopathology and (b) indirect immunofluorescence using 1 M NaCl‐split skin at titre 1:40
FIGURE 3
FIGURE 3
Immunoblotting analysis of the patient's serum. In immunoblotting of normal human dermal extract (Dermal), the patient serum reacted with the 200 kDa laminin gamma‐1, but not with the 290 kDa type VII collagen (left). No positive reactivity was seen in immunoblotting using purified human laminin‐332 (light). (Performed by the Study Group of Kurume University)

References

    1. Ujiie H, Iwata H, Yamagami J, Nakama T, Aoyama Y, Ikeda S, et al. Clinical guidelines of pemphigoid (including epidermolysis bullosa acquisita). Jpn J Dermatol. 2017;127:1483–521. - PubMed
    1. Dainichi T, Kurono S, Ohyama B, Ishii N, Sanzen N, Hayashi M, et al. Anti‐laminin gamma‐1 pemphigoid. Proc Natl Acad Sci USA. 2009;106(8):2800–5. 10.1073/pnas.o809230106 - DOI - PMC - PubMed
    1. Dainichi T, Koga H, Tsuji T, Ishii N, Ohyama B, Ueda A, et al. From anti‐p200 pemphigoid to anti‐laminin gamma1 pemphigoid. J Dermatol. 2010;37:231–8. - PubMed
    1. Meijer JM, Diercks GFH, Schmidt E, Pas HH, Jonkman MF. Laboratory diagnosis and clinical profile of anti‐p200 pemphigoid. JAMA Dermatol. 2016;152:897–904. - PubMed
    1. Kridin K, Ahmed AR. Anti‐p200 pemphigoid: a systematic review. Front Immunol. 2019;10. eCollection 2019. 10.3389/fimmu.2019.02466 - DOI - PMC - PubMed

Publication types

LinkOut - more resources